Overexpression of MCL1 is common in human cancers due to its pro-survival effect5,6 and has been reported to contribute to both tumorigenesis and resistance to multiple anti-cancer chemotherapeutics including anti-tubulin drugs7,8, platinum-containing compounds9, and therapeutics targeting other anti-apoptotic BCL-2 family members10,11. Here, MCL1 is linked to cancer.